Drug-Induced Liver Injury (DILI) and Medical Cannabis
Short answer
Drug-induced liver injury (DILI) is damage to the liver caused by a medicine, a supplement or an herbal product. Cannabis does not treat it, and no study has tested it for that. CBD itself is linked to rising liver enzymes in clinical trial data, most of all at high doses and alongside the seizure medicine valproate [1]. Anything you swallow passes through the liver before it reaches the blood, and drug interactions apply to every form; smoke and vapor add a risk for the airways rather than the liver. Whether any of it fits you is a decision to make with a physician who sees your labs and your medicine list.
What is known comes from a review of clinical trial data, case reports, and experiments in mice and in liver cells. Every study on this page is labeled by who was studied, and the full picture starts at what the research shows.
When liver injury is an emergency: signs to get care now
Most drug-induced liver injury is found on a blood test and settles once the medicine is stopped. A small share turns into acute liver failure, and that can happen within days. If any of the signs below appear, get emergency care first; questions about cannabis can wait.
- Yellow skin or eyes together with new confusion, unusual sleepiness or strange behavior.
- Bleeding gums, nosebleeds or bruises that appear without a reason.
- Strong pain under the right ribs, or a belly that swells quickly.
- Vomiting that will not stop, so you cannot keep fluids or your medicines down.
- Dark urine and yellowing eyes a few days or weeks after starting a new medicine, herb or supplement.
- You or someone else may have taken too much acetaminophen (Tylenol), even with no symptoms yet.
If acetaminophen may be involved
Call 911, or call Poison Control at (800) 222-1222 [2] right away. An acetaminophen overdose can feel like nothing for the first day while the liver is already being damaged, and the antidote works best when it is started early.
Do not stop a prescribed medicine on your own
If a blood test shows high liver enzymes and you suspect a medicine, call the doctor who prescribed it the same day. Some medicines, seizure drugs and tuberculosis treatment among them, must not be stopped abruptly without a plan.
What to tell the emergency team
- Every prescription, over-the-counter pill, herb, supplement, CBD and cannabis product from the last two months, with doses.
- When the first symptom appeared and when each medicine was started.
- Bring the bottles or photos of the labels. Exact names help the team rule causes in or out faster.
How this guide was put together
- Each research number has its source next to it, and the full list sits at the foot of the page.
- Every study is tagged with what was actually tested: patients, mice or liver cells in a dish.
- Prescription Epidiolex, state-program products and shelf hemp CBD are discussed separately, because the data differ.
- The medical content was reviewed by physicians licensed in the states where we see patients. Who they are.
A medicine you needed, then yellow eyes and weeks of blood tests
It usually starts with something reasonable: an antibiotic for an infection, months of tuberculosis treatment, a seizure medicine that finally worked, a supplement a friend swore by. Then a routine blood test comes back with liver numbers several times too high, or someone notices your eyes look yellow.
What follows is hard in its own way. The treatment you relied on is stopped. Every new pill now feels suspicious. You wait on the next liver panel, and nobody can tell you exactly what is safe to take while you recover.
The treatment you had to stop
Antibiotics, TB drugs and seizure medicines are among the common causes. Stopping one can leave the original illness without cover until a replacement is found.
Waiting on every liver panel
ALT, ALP and bilirubin become numbers you check in the patient portal before breakfast. Knowing what each one means makes the wait less blind.
When “natural” was not harmless
Herbs and supplements cause liver injury too. Two people developed it after an herbal sleep aid containing Corydalis, a case report that is not about cannabis [3]. CBD belongs in the same conversation.
The way through is unglamorous: a physician who looks at your whole medicine list and your recent labs before anything new is added, cannabis and CBD included. This guide gives you the facts to bring to that conversation.
Recovering from DILI, on a liver-risky medicine, or already taking CBD: where to start
Pick the line closest to where you are now; the card written for that case stays on screen.
You were just told you have DILI
First comes finding the medicine behind it and watching the numbers fall. Symptoms, the tests doctors run and what recovery usually looks like are the parts to read now.
You take a medicine that can strain the liver
Isoniazid, valproate and several other daily medicines are known causes of liver injury. Adding CBD or THC on top is mainly a question of interactions, and the evidence differs by drug.
You take CBD and your liver enzymes rose
CBD is a recognized cause of enzyme rises. Tell the doctor who ordered the test what you take and how much, and let them decide what to stop.
You already live with liver disease
A liver that works less well clears cannabinoids differently, and a transplant list has rules of its own. Your hepatologist belongs in any decision.
Epidiolex and valproate are in the same treatment plan
Most of the clinical data on CBD and the liver comes from exactly this combination, mostly in children with epilepsy syndromes. Regular liver tests are part of that plan.
You already have a medical card
A liver injury and any changed medicines are new history for your physician. Raise them at your next renewal, together with your latest liver panel.
What is drug-induced liver injury (DILI)? Definition, how common it is and ICD-10 codes
Drug-induced liver injury means the liver has been harmed by something you took: a prescription drug, an over-the-counter pain reliever, an herbal remedy or a dietary supplement. Doctors abbreviate it DILI and also call it drug-induced hepatotoxicity or toxic liver disease. It shows up as liver enzymes or bilirubin rising on a blood test, sometimes with jaundice, and it usually improves once the cause is stopped [4][5].
How common is it? Uncommon for any single medicine, yet among the more frequent reasons a drug gets a warning label, and the leading cause of sudden liver failure in the United States when acetaminophen overdoses are counted. Because hundreds of products can do it, the NIH keeps a free reference on each one, LiverTox [6], which doctors use when they suspect a medicine.
Intrinsic DILI
Depends on dose?
Yes. Take enough, and anyone’s liver is harmed.
Predictable?
Largely, which is why dose limits exist.
Typical example
Acetaminophen above the safe daily amount, often within a day or two [4].
Idiosyncratic DILI
Depends on dose?
Not in a simple way. It strikes a small number of people at normal doses.
Predictable?
No. It often appears weeks or months after starting.
Typical example
Amoxicillin-clavulanate, isoniazid, some seizure medicines and supplements [4].
ICD-10-CM codes for drug-induced liver injury
There is no single DILI code. Records usually pair a K71 code, which describes what happened to the liver, with a T code naming the medicine and whether it was a side effect at a normal dose or a poisoning. K72 is added when the liver fails. The list below follows the code set published by CMS [7]; your record may use a more specific code.
Filter by the part of the discharge papers you are trying to read.
| Code | What it means |
|---|---|
| K71.0 | Toxic liver disease with cholestasis (bile flow slowed) |
| K71.10, K71.11 | Toxic liver disease with hepatic necrosis (liver cells dying), without or with coma |
| K71.2 | Toxic liver disease with acute hepatitis |
| K71.6 | Toxic liver disease with hepatitis, not elsewhere classified |
| K71.7 | Toxic liver disease with fibrosis and cirrhosis of the liver |
| K71.9 | Toxic liver disease, unspecified |
| K72.00, K72.01 | Acute and subacute hepatic failure, without or with coma |
| T39.1X5A | Adverse effect of 4-aminophenol derivatives (acetaminophen) at a normal dose, first visit |
| T39.1X1A | Poisoning by 4-aminophenol derivatives (acetaminophen), accidental, first visit |
| T36.0X5A | Adverse effect of penicillins, such as amoxicillin-clavulanate |
| T37.1X5A | Adverse effect of antimycobacterial drugs, such as isoniazid |
| T42.6X5A | Adverse effect of other antiepileptic and sedative-hypnotic drugs, valproate among them |
| T46.6X5A | Adverse effect of antihyperlipidemic drugs, such as statins |
| T40.715A | Adverse effect of cannabis, first visit |
| T40.725A | Adverse effect of synthetic cannabinoids (K2, Spice), first visit |
| F12.- | Cannabis-related disorders, a separate family that describes use, not liver injury |
No codes match this filter.
The final letter A marks a first visit; D and S mark follow-up visits and late effects. An F12 code on a chart does not mean the liver injury came from cannabis; it only records that cannabis use was noted.
Which drugs and supplements can cause liver injury? Common culprits and how the damage happens
More than a thousand medicines and herbal products have been linked to liver injury, and LiverTox [6] lists what is known for each. In US case series a handful of groups come up again and again: antibiotics, tuberculosis drugs, seizure medicines, acetaminophen, and herbal and dietary supplements, whose share has grown over the last two decades [4].
What were you taking when it started?
Choose the product closest to your story; its group is outlined below and a note for your doctor opens under the cards.
Intrinsic
Acetaminophen
Safe at labeled doses, toxic above them. Hidden doubles are common: cold remedies and prescription pain pills often contain it too.
Idiosyncratic
Antibiotics and TB medicines
Amoxicillin-clavulanate is the most frequently reported single cause in many series; isoniazid, rifampin and pyrazinamide need regular liver checks [4].
Idiosyncratic
Seizure medicines
Valproate, phenytoin and carbamazepine. Valproate matters twice on this page, because it also raises the liver risk of CBD [1].
Idiosyncratic
Statins and other daily medicines
Statins often nudge enzymes up a little; real injury is rare. Some antifungals, methotrexate and a few heart medicines are on the watch list too.
Mostly idiosyncratic
Herbs and supplements, CBD included
Green tea extract, bodybuilding products, kava and blends with unclear contents. CBD has its own section: CBD and the liver.
Toxic effect
Stimulants
Methamphetamine, cocaine and MDMA can injure the liver through overheating, low blood flow and direct toxicity, sometimes severely.
Choose a product above to see what to tell your doctor about it.
Acetaminophen. Say how much you took per day, for how many days, and list every combination product. If an overdose is possible, that is an emergency: see the warning signs.
An antibiotic. Name it and the dates of the course. Injury from amoxicillin-clavulanate can begin weeks after the last dose, so a finished course still counts.
TB treatment. The TB team usually decides which drug to pause and how to restart safely. Do not stop on your own, because untreated tuberculosis has its own risks.
A seizure medicine. Stopping it suddenly can bring on seizures, so changes go through the neurologist. Mention any CBD or Epidiolex as well.
A statin. A small enzyme rise is common and often harmless; a large one with symptoms is not. Bring the dose and the date it started.
Herbs or CBD. Bring the bottles. Supplements and shelf CBD are not checked like medicines, so the label is the only clue to what was inside.
Stimulants. Say what was used and when, plainly. The team needs it to choose tests and treatment, not to judge.
How the damage happens
Toxic by-products
The liver breaks most medicines down. Sometimes the leftover piece is more harmful than the drug. With acetaminophen, a by-product called NAPQI builds up once the liver’s protective glutathione runs out, and liver cells die.
Enzyme traffic (CYP450)
A family of liver enzymes called cytochrome P450 handles most drugs. When two substances use the same enzyme, one can slow or speed the breakdown of the other, so levels and by-products shift. CBD works on several of these enzymes, which is why it matters here.
Immune reaction
In some people the immune system treats a drug bound to liver proteins as a threat. That explains the delay of weeks, and why fever, rash or high eosinophils can come with it.
Drug-induced liver injury symptoms: does it cause pain or fever?
Many people feel nothing at all. The injury is found because a routine blood test shows ALT, AST or ALP several times above normal, often during a medicine that is monitored for exactly that reason. When symptoms do appear, they tend to come in this order:
- Tiredness that is out of proportion to what you do, and a poor appetite.
- Nausea, sometimes with vomiting.
- Dark, tea-colored urine and pale or clay-colored stools.
- Yellow eyes or skin (jaundice), the sign that bilirubin is rising.
- Itching all over, especially when bile flow is affected.
Pain under the right ribs
Pain is not typical, but a dull ache under the right ribs can come with an inflamed, slightly swollen liver. Sharp, strong pain points to other causes, such as gallstones, and needs a same-day assessment.
Fever, rash and the DRESS pattern
Fever, a spreading rash and a high eosinophil count suggest an immune reaction to the drug. When skin, blood and organs are involved together, doctors call it DRESS, and it is treated urgently [5].
After a liver injury, is medical cannabis worth raising for you?
Fourteen short questions about your liver, your medicines and the symptom you want help with. You get a summary of how your answers fit what is known, and what to take to a physician. Your answers stay in this browser.
14 questions · about a minute · your answers stay in this browser
How is drug-induced liver injury diagnosed? Patterns, criteria, RUCAM and Hy’s law
There is no single blood test for DILI. It is a diagnosis of exclusion: doctors first rule out viral hepatitis, autoimmune hepatitis, alcohol, a blocked bile duct and low blood flow to the liver, and then look at the timing between the medicine and the lab changes [4][5].
The tests, one by one
ALT and AST main test
Enzymes that leak out of injured liver cells. ALT is more specific to the liver. A rise many times above the upper limit points to damage of the liver cells themselves.
ALP and GGT pattern
Alkaline phosphatase rises when bile flow is disturbed. GGT confirms that a high ALP comes from the liver rather than from bone.
Total bilirubin severity
The yellow pigment the liver clears into bile. When it rises along with ALT, the liver is struggling to do its job, not only showing irritation.
INR severity
A clotting test. The liver makes clotting proteins, so a rising INR without a blood thinner is a sign of failing liver function.
Hepatitis A, B, C and E, autoimmune markers rules out
Viral and autoimmune hepatitis look just like DILI on enzymes, so they must be excluded before a medicine is blamed.
Ultrasound or other imaging rules out
Shows whether stones or a tumor are blocking the bile ducts and whether the liver looks scarred.
Liver biopsy sometimes
Not routine. Used when the cause stays unclear, when enzymes keep rising after the drug is stopped, or when autoimmune hepatitis is suspected.
When lab changes count as drug-induced liver injury
An international expert group set the thresholds most guidelines now use. Any one of these is enough [8]:
| Criterion | What it means |
|---|---|
| ALT at least 5 × ULN | Clear injury to liver cells [8] |
| ALP at least 2 × ULN | Bile flow injury, when bone disease is excluded and GGT is also high [8] |
| ALT at least 3 × ULN and total bilirubin above 2 × ULN | Injury that is already affecting liver function [8] |
Three patterns, read from the R ratio
R compares how far ALT and ALP have risen, each divided by its own upper limit: R = (ALT ÷ ALT upper limit) ÷ (ALP ÷ ALP upper limit). It is calculated from the first abnormal results [4].
| Pattern | R value | What it suggests |
|---|---|---|
| Hepatocellular | 5 or more | Damage mainly to liver cells; acetaminophen, isoniazid and many supplements |
| Mixed | Between 2 and 5 | Features of both |
| Cholestatic | 2 or less | Bile flow mainly affected; amoxicillin-clavulanate is a classic cause; often slower to settle |
RUCAM: how likely is it that this medicine did it?
RUCAM is a scoring sheet doctors fill in for each suspected product. Points are given for timing, the course after stopping, risk factors, other medicines, other causes ruled out, known liver toxicity of the drug and what happened on re-exposure [9].
| Score | Causality |
|---|---|
| 0 or below | Excluded |
| 1 to 2 | Unlikely |
| 3 to 5 | Possible |
| 6 to 8 | Probable |
| 9 or more | Highly probable |
DILI calculator: R-ratio and Hy’s law check from your lab results
If you have a liver panel in hand, you can see where your numbers fall in the tables above: the R ratio and its pattern, how far each value is above its upper limit, and whether the combination matches the expert thresholds or Hy’s law. It reads the tables for you; it cannot tell whether a medicine caused the change, because that needs the other causes ruled out first [4].
ALT
The ALT value on your liver panel or in the patient portal, in U/L. Use the first abnormal result if you have several.
The higher number of the reference range printed next to the result. Each lab sets its own.
ALP (alkaline phosphatase)
Listed as ALP or alkaline phosphatase on the same panel, in U/L, taken the same day as the ALT.
The top of the ALP reference range on your report. Children and teenagers have higher ranges because of growing bones.
Total bilirubin
Total, not direct, bilirubin in mg/dL. Leave it untouched if your panel did not include it.
The top of the total bilirubin range printed on the same report.
Move the sliders to your numbers. Nothing is shown until you do.
–
R ratio: the ALT rise divided by the ALP rise, each against its upper limit
- Cholestatic
- Mixed
- Hepatocellular
- ALT
- –
- ALP
- –
- Total bilirubin
- –
- Expert-group lab threshold
- –
- Hy’s law pattern
- –
A reading aid, not a diagnosis. R is meant for the first abnormal results; later results can shift the pattern as the liver heals. Only your doctor can rule out the other causes that look the same on paper [4][8].
Drug-induced liver injury guidelines and severity: FDA, ACG, EASL and DILIN
Four sources shape how DILI is handled in the United States and Europe. They agree on most things: stop the suspected product, rule out other causes, grade severity by bilirubin and clotting, and refer early when the liver starts to fail.
FDA guidance: Drug-Induced Liver Injury, Premarketing Clinical Evaluation, 2009 [10]
Written for drug makers testing new medicines. It made Hy’s law the standard alarm signal in trials and describes how often liver tests should be checked when a signal appears.
What it means for you: the liver warnings on a drug label often trace back to cases found this way, and those warnings are why some medicines come with scheduled blood tests.
American College of Gastroenterology clinical guideline, 2021 [4]
The main US guideline for idiosyncratic DILI: how to recognize it, which tests exclude other causes, how to use the R ratio and RUCAM, when steroids are reasonable, and when to refer to a transplant center.
What it means for you: it is the playbook your gastroenterologist or hepatologist is most likely to follow.
European Association for the Study of the Liver practice guideline, 2019 [5]
Covers the same ground in more detail, including herbal and dietary supplements, chronic DILI, special groups such as people with existing liver disease, and immune-mediated cases.
What it means for you: its advice on supplements applies directly to shelf CBD products.
Drug-Induced Liver Injury Network (DILIN) [11]
A network of US medical centers, funded by the NIH, that has collected and studied cases since 2004. Its severity scale and its case data underpin much of what is known about which drugs cause DILI in the US.
What it means for you: the 1-to-5 severity grade on your chart most likely comes from DILIN.
How severe is it? The DILIN scale
| Grade | What defines it | What it means for you |
|---|---|---|
| 1 Mild | Raised ALT or ALP, but total bilirubin below 2.5 mg/dL and INR below 1.5 [4] | Usually managed at home with repeat blood tests |
| 2 Moderate | Bilirubin 2.5 mg/dL or more, or INR 1.5 or more [4] | Jaundice is likely; closer follow-up |
| 3 Moderate to severe | As grade 2, plus a hospital stay or a longer one because of the liver | Care in the hospital |
| 4 Severe | Bilirubin 2.5 mg/dL or more plus signs of liver failure (INR 1.5 or more, fluid in the belly, confusion) or failure of another organ [4] | Specialist and often transplant center involvement |
| 5 Fatal | Death or liver transplant because of the injury | The outcome all monitoring aims to prevent |
The international expert group uses a shorter four-step scale (mild, moderate, severe, fatal or transplant) built on the same signs [8]. Either way, rising bilirubin and INR matter more than how high ALT climbs.
How is drug-induced liver injury treated?
For most people treatment is simpler than they fear: the suspected product is stopped and the liver repairs itself. What else is done depends on the cause and on how hard the liver is hit [4][5].
-
Stop the suspected product
The prescriber decides what to stop and what to replace it with, so the original condition stays covered.
-
Use an antidote when there is one
N-acetylcysteine (NAC) refills the liver’s glutathione after an acetaminophen overdose and works best when given early.
-
Steroids for an immune reaction
Considered when a biopsy or blood markers show the injury is immune-driven, and only on a specialist’s decision.
-
Close checks, transplant if needed
Repeat liver tests until they settle; early referral to a transplant center if the liver begins to fail.
How long does drug-induced liver injury last? Recovery time, reversal and the risk of cirrhosis
Most people recover fully once the cause is stopped. How quickly depends on the pattern: injury to liver cells usually settles faster, while the cholestatic pattern, where bile flow is affected, can linger and keep itching going for a long while [4][5].
The product is stopped
Enzymes may still climb for a few days before they turn. That alone is not a sign of failure.
The following weeks
Repeat blood tests should show ALT and bilirubin falling. Keep every result with its date.
The following months
Cholestatic injury and itching can take longer. Your doctor decides when testing can be spaced out.
Still abnormal after six months
The ACG guideline calls this chronic DILI and recommends a closer look for another liver disease [4].
Can drug-induced liver injury be reversed or cured?
In most cases the liver returns to normal on its own, which is about as close to a cure as medicine gets. Treatment does not speed that up much; avoiding the product again is what keeps it that way.
Can DILI lead to cirrhosis?
Rarely. Long-lasting injury, repeated exposure to the same drug or certain patterns that damage the bile ducts can scar the liver over time, and records then carry K71.7. That is why abnormal tests after six months are followed up rather than ignored [5].
While you recover
Tap each habit once it is part of your week.
Already have liver disease or cirrhosis? What changes with cannabis and CBD
People with hepatitis, fatty liver disease or cirrhosis ask about cannabis for pain, sleep or nausea just as often as anyone else. The difference is that their liver has less spare capacity to clear what they take, and the data on them are thin.
How a weaker liver handles cannabinoids cells and review
THC and CBD are both broken down in the liver. In liver cell experiments, a by-product of CBD called 7-hydroxy-CBD was toxic, and the enzyme CYP2D6 cleared it [13]. People with impaired liver function or low CYP2D6 activity may therefore be at higher risk, and the 2024 clinical review advises against starting CBD when enzymes are already above three times normal without a specialist [1].
Cirrhosis in short background
Cirrhosis is advanced scarring that replaces working liver tissue. Care focuses on the cause (alcohol, viral hepatitis, fatty liver), on screening for complications and on adjusting medicine doses. Sedating substances need extra caution because they can mask or worsen confusion from liver disease (hepatic encephalopathy).
Transplant waiting lists policy varies
Transplant centers set their own rules on cannabis use, and they differ. Some treat medical use like any other prescribed medicine; others ask for a period without use. Talk to the transplant team before starting or stopping, and keep any medical recommendation on file.
Hepatitis or fatty liver alongside DILI background
An existing liver disease makes DILI harder to spot and slower to settle. Guidelines advise more frequent tests for people with liver disease who start a medicine with known liver risk [5]. The same caution makes sense for CBD.
Is medical cannabis worth raising with your doctor after drug-induced liver injury?
Sometimes, and the reason matters. Cannabis has not been studied as a treatment for DILI, and nothing suggests it helps a liver heal. What people do reasonably raise is everything around the injury: pain that used to be covered by a medicine now off limits, nausea, poor sleep, or a product they were already using and are unsure about.
Not now
While the injury is active
As long as enzymes or bilirubin are still rising, or you are in the hospital, nothing new should be added. Your liver team decides when that phase is over.
Later, as a question
Symptoms once labs are stable
Pain, nausea or sleep problems are fair to discuss when tests have settled, with a physician who sees your labs and every medicine you take.
Not for the liver
Repairing the liver itself
No study shows cannabis or CBD helps an injured liver. If anything, CBD at high doses is on the list of possible causes.
An online evaluation looks at your situation rather than at the diagnosis in general: your liver history, your current medicines and your state’s rules come before any decision about a recommendation.
Why the liver matters for cannabinoids: CB1, CB2 and CYP450 metabolism
The body makes its own cannabis-like messengers and the receptors that answer them, together called the endocannabinoid system; the endocannabinoid system explainer covers it in full. The liver carries these receptors too, but its bigger role is chemical: it is where THC and CBD are broken down.
That matters most for anything swallowed. Edibles, capsules and oils taken by mouth pass through the liver before they reach the rest of the body, a step called first-pass metabolism, so the liver meets the full dose first. Inhaled cannabis reaches the blood through the lungs, yet it still ends up in the liver to be cleared.
CB1 and CB2 in the liver in animals
In animal models, CB1 activity is tied to fat buildup and scarring, while CB2 tends to calm inflammation. In mice given a paracetamol (acetaminophen) overdose, the body’s own cannabinoid signaling was studied as part of the injury response [14]. None of this has been turned into a treatment for people.
CYP3A4, CYP2C19, CYP2C9 and CYP2D6 drug label
These liver enzymes break down THC and CBD and also many common medicines. The prescribing information for Epidiolex, the prescription CBD, warns that CBD can raise or lower the levels of drugs that share these routes [15]. A high-dose cannabis extract also switched on several of these enzymes in mice [16].
7-hydroxy-CBD and 7-carboxy-CBD cells and mice
CBD is turned into two main by-products. In human liver cells, 7-hydroxy-CBD was clearly more toxic than 7-carboxy-CBD, and CYP2D6 broke it down [13]. In mice, blood levels of 7-carboxy-CBD were 34 times those of CBD itself [17], which is one reason researchers look at the by-products and not only at CBD.
THC cells only
The liver data on THC come from a computer analysis of possible targets checked in liver cells in a dish, which pointed to oxidative stress and bile pathways [18]. It shows where to look next; it does not show that THC injures the liver in people.
What the research shows, from strongest to weakest
In short: no study has tested cannabis as a treatment for drug-induced liver injury. The human data describe CBD as a possible cause of liver enzyme rises, and most of the rest comes from mice and liver cells.
Not every study can answer the same question. Pooled trial data can show how often something happens with a treatment compared with a placebo. A case report shows that something can happen to one person. Mouse and cell work suggest how it might happen. The table puts the liver studies on those levels.
| Level | What exists for the liver | What it can and cannot tell you |
|---|---|---|
| Clinical trial data, reviewed | A 2024 review pooling trials of CBD against placebo, mostly prescription CBD in epilepsy [1]. | Shows CBD raises the odds of enzyme rises and DILI in those groups. Says little about adults over 50 or shelf products. |
| Case reports | Toxic hepatitis after synthetic Spice/K2 [12]; two cases after an herbal sleep aid, not cannabis [3]. | Show that injury can happen. Cannot give a rate. |
| Animal studies | High-dose cannabis extract in mice, alone and with acetaminophen [16][19]. | Point to doses and drug pairs worth watching. Mouse doses do not translate to people. |
| Cell studies | Human liver cells exposed to CBD, its by-products, valproate or THC [20][13][21][18]. | Suggest mechanisms. A dish is not a body. |
What kinds of studies is this evidence built on?
How to read it: each row is one type of published study on cannabinoids and liver injury, and a longer bar means more studies of that type. Strong designs are at the top in dark blue. Gray rows are background work, meaning reviews, animal studies and cell studies, which suggest ideas but cannot show what happens to patients.
Show as a table
| Design | Studies |
|---|---|
| Meta-analyses | 1 |
| Randomized trials | 1 |
| Cohort studies | 1 |
| Case reports | 4 |
| Narrative reviews (background) | 6 |
| Animal studies (background) | 10 |
| Cell studies (background) | 6 |
Browse the studies cited here
One card per paper this page relies on, in plain words. Papers that only touch on cannabis carry a label saying so.
Clinical guidance for CBD and the liver
CBD raised the odds of liver enzyme rises and of DILI compared with placebo; valproate raised them further. Most events happened above 1,000 mg a day [1].
Toxic hepatitis after Spice/K2
A 45-year-old man developed severe liver cell injury after a week of a synthetic cannabinoid and was treated with N-acetylcysteine [12].
An herbal sleep aid and liver injury
Two people developed liver injury after a sleep aid containing Corydalis; it resolved once they stopped [3].
A CBD-rich extract at high doses
At the highest dose, ALT rose about fourfold and 3 of 8 mice became severely ill; liver enzymes that process drugs were switched on [16].
CBD-rich extract plus acetaminophen
In older female mice, the lower extract dose with acetaminophen caused more deaths than the higher one, a result the authors called paradoxical [19].
CBD and valproate in 3D liver cell clusters
Damage appeared only after a week or more and grew with dose; together the two drugs were more toxic than either alone [20].
Which CBD by-product is toxic
7-hydroxy-CBD harmed liver cells more than 7-carboxy-CBD, and the enzyme CYP2D6 cleared it [13].
CBD in human liver cells
CBD caused cell death, stalled cell division and stress in the cells’ protein factory at higher concentrations [21].
Possible targets of THC in the liver
A network analysis named 22 core targets, and 10 genes changed in liver cells exposed to THC [18].
How the body processes 7-carboxy-CBD
Mapped how this by-product is processed further; in mice its blood level was 34 times that of CBD [17].
The body’s own cannabinoids in paracetamol injury
Looked at endocannabinoid signaling during acetaminophen liver injury in mice; no cannabis product was tested [14].
A biomedical question-answering system
A computer system proposed a mechanism for CBD and valproate liver toxicity as a test question; it is a hypothesis, not a finding [22].
No studies of this type are cited here.
How big was the effect? Liver enzyme and DILI odds with CBD, and who the data apply to
The clearest human numbers come from one 2024 review that pooled clinical trial data on CBD [1]. It compared people taking CBD with people taking a placebo, and people taking CBD together with valproate with those taking CBD without it.
How much more often did liver problems show up with CBD?
How to read it: each row is one comparison. The dot is the best estimate of how much higher the odds were, and the line around it is the range the true value most likely falls in. The gray line marks no difference. Everything to its right means the problem showed up more often.
estimate · likely range (95% CI) · no difference
CBD compared with placebo
- Liver enzymes rose5.9× higher odds (3.8 to 8.9) [1]
- Drug-induced liver injury4.8× higher odds (2.5 to 9.5) [1]
CBD taken with valproate, compared with CBD without it
- Liver enzymes rose6.9× higher odds (4.7 to 10.1) [1]
- Drug-induced liver injury5.1× higher odds (2.2 to 11.6) [1]
Show as a table
| Outcome | Compared with | Odds ratio (95% CI) |
|---|---|---|
| Liver enzyme elevation with CBD | Placebo | 5.85 (3.84 to 8.92), p < 0.001 [1] |
| Drug-induced liver injury with CBD | Placebo | 4.82 (2.46 to 9.45), p < 0.001 [1] |
| Liver enzyme elevation, CBD with valproate | CBD without valproate | 6.92 (4.74 to 10.09), p < 0.001 [1] |
| Drug-induced liver injury, CBD with valproate | CBD without valproate | 5.05 (2.2 to 11.6), p < 0.001 [1] |
Who these numbers come from
Mostly people taking prescription CBD (Epidiolex) at high doses for epilepsy syndromes such as Dravet and Lennox-Gastaut, many of them children and many also taking valproate. The authors note that the studies were mainly in people under 50, that symptoms and follow-up tests were reported unevenly, and that there are no data on non-medical or unregulated CBD [1]. Moving these numbers onto a dispensary tincture or a hemp gummy is not supported either way.
Can CBD cause liver injury? Epidiolex monitoring, hemp CBD and delta-8 products
It can, which surprises many people who chose CBD because it sounded gentle. The prescribing information for Epidiolex lists raised liver enzymes as a known risk and asks doctors to check transaminases and bilirubin before treatment starts and again during the first months [15]. The risk is higher at larger doses and alongside valproate or clobazam.
Hemp-derived CBD oils, gummies and delta-8 THC products are sold outside FDA drug oversight. The FDA has warned that their real content can differ from the label and that some carry contaminants or more THC than stated [23][24]. With a liver that is healing, not knowing the dose is the problem.
How state medical programs differ from the shelf
In states with a medical program, card holders buy at licensed dispensaries, which is the legal term for the program’s stores. Products there must pass state lab tests and carry THC and CBD amounts on the label.
Lab testing
State-program product
Tested under state rules for potency and common contaminants.
Hemp CBD or delta-8 off the shelf
Testing is up to the seller, and results are rarely checked.
What the label tells you
State-program product
THC and CBD per serving, batch number and test date.
Hemp CBD or delta-8 off the shelf
A number that may not match what is inside.
Who looked at your liver first
State-program product
A licensed physician reviewed your history before the recommendation.
Hemp CBD or delta-8 off the shelf
Nobody.
Where it is sold
State-program product
Licensed dispensaries, to registered patients.
Hemp CBD or delta-8 off the shelf
Gas stations, vape shops, supermarkets and online.
What are you taking?
Pick the product you use to see what your doctor will want to know about it.
Epidiolex. Your prescriber already schedules liver tests. Bring the latest results to every visit and mention any other CBD on top, because the doses add up.
Hemp CBD oil or gummies. Bring the package and, if the brand publishes one, its lab certificate. Say how many drops or pieces a day and for how long.
Delta-8. It is a THC-like compound usually made from hemp CBD by chemical conversion, outside state programs. Name the product, the amount and where you bought it.
From a state program. Read the THC and CBD per serving off the label and say how often you use it. Tested content makes it easier for the doctor to judge.
Not sure. Describe it: oil, gummy, vape or capsule, where it came from and how long you have used it. That is useful information too.
If your enzymes went up while you were taking CBD
Tell the doctor who ordered the test, with the product and the dose. Do not decide alone whether to stop it, and do not stop a prescribed medicine to keep the CBD. Often the answer is a pause and a repeat test, but that is a call for someone who sees the whole picture.
Drug interactions: valproate, clobazam, acetaminophen and other liver-processed medicines
For most people who ask about cannabis after a liver injury, the real question is not cannabis alone but cannabis on top of the medicines they already take. The strength of the evidence differs a lot from one medicine to the next, so each entry below says what kind of data it rests on.
What is on your medicine list?
Have your bottles or the pharmacy printout at hand and tap each medicine you take; only those entries stay open below.
Valproate (Depakote, Depakene) clinical data
The best-documented interaction. In pooled trial data, people taking CBD together with valproate had about 6.9 times higher odds of liver enzyme rises (95% CI 4.74 to 10.09) and about 5.1 times higher odds of DILI (2.2 to 11.6) than people taking CBD without it [1]. In human liver cell clusters, the two together were more toxic than either alone, and the damage appeared only after a week or more [20].
Clobazam (Onfi) pharmacokinetic
CBD slows the enzyme CYP2C19, which raises blood levels of norclobazam, the active product of clobazam [1]. The usual result is more sleepiness rather than liver injury, and prescribers often lower the clobazam dose.
Acetaminophen (Tylenol) in mice only
In older female mice given a CBD-rich cannabis extract and then acetaminophen, liver injury was severe, and 37.5% of the animals in the lower extract dose group (116 mg/kg) died, more than in the higher dose group [19]. The same extract switched on liver enzymes that process acetaminophen [16]. This has not been shown in people, but it is a reason to tell your doctor about every acetaminophen product you use.
Isoniazid, rifampin and other TB medicines no data
None of the studies on this page tested cannabis or CBD with tuberculosis drugs. Isoniazid is itself a common cause of DILI, and rifampin speeds up the same liver enzymes that clear CBD [15]. With no data, the TB team decides.
Statins no data
No study here looked at statins with CBD. Several statins use CYP3A4 or CYP2C9, the routes CBD can slow according to the Epidiolex label [15], so a pharmacist check is reasonable.
Warfarin and other blood thinners drug label
Warfarin is cleared by liver enzymes that CBD can slow, which may raise its effect and the risk of bleeding [15]. A failing liver also makes fewer clotting proteins, so INR is checked closely after DILI anyway.
Medicines that block CYP2D6, or a slow CYP2D6 type cells only
Some antidepressants (fluoxetine, paroxetine), bupropion and quinidine block CYP2D6, and some people are born with a slow version of it. In liver cells, CYP2D6 cleared the toxic CBD by-product 7-hydroxy-CBD, so blocking it raised the toxicity [13]. This is a laboratory signal, not a human finding.
No entries match this filter.
Show all interactions as a table
| Medicine | What was seen | Type of data | Source |
|---|---|---|---|
| Valproate | Higher odds of enzyme rises and DILI; more toxic together in cells | Clinical; cells | [1][20] |
| Clobazam | Higher norclobazam levels via CYP2C19 | Pharmacokinetic | [1] |
| Acetaminophen | Severe liver injury and deaths with extract | Mice only | [19][16] |
| CYP2D6 blockers | More toxicity from 7-hydroxy-CBD | Cells only | [13] |
| Warfarin | Possible stronger effect | Drug label | [15] |
| Isoniazid, statins | Not studied with cannabinoids here | No data | None |
Questions to ask your pharmacist
- Which of my medicines are processed by CYP3A4, CYP2C19 or CYP2D6?
- Does anything I take already raise liver enzymes?
- How many acetaminophen-containing products are on my list, prescription and over the counter?
- Which blood test should be repeated if I start or stop CBD?
Bring the full list, supplements included, to any evaluation; the physician checks the pairs before anything else.
Smoked, vaped, eaten or under the tongue: what each form avoids and what stays for your liver
Cannabis is smoked, vaped, eaten, swallowed as capsules, held under the tongue, rubbed on skin or worn as a patch. No study here compared these forms for the liver, so this page does not rank them. It can say which parts of the risk each form skips and which it keeps. The choice of form belongs to you and your physician.
Which form are you asking about?
The card on what every form shares is always open; pick a form to add the part that is specific to it.
Smoking: joints, blunts, pipes, bongs
The cannabinoids reach the blood through the lungs, so the liver does not get the first pass. It still clears them afterward. Smoke brings its own airway irritation, and shared pipes and joints pass germs.
Vaping and dabbing
Heating instead of burning avoids smoke, but the hot aerosol still reaches the airways. Cartridges of unknown origin can contain synthetic cannabinoids, and a synthetic product is the one cannabinoid with a documented severe liver injury on this page [12]. Concentrates are strong enough that a small slip is a large dose.
Edibles, drinks and capsules
No smoke, but the whole dose goes through the liver before it reaches the blood, and the high-dose CBD data that link CBD to liver injury come from oral use [1]. The effect starts late and lasts hours, and a second helping taken because nothing seemed to happen is a common way to take too much.
Tinctures, oils and mouth sprays
Drops under the tongue or a cheek spray are measured in drops or sprays, which makes the dose easy to write down. Much of each dose is still swallowed, so the liver and the interactions stay in play.
Creams, balms and patches
Creams and balms act mostly where they are applied. Transdermal patches are different: they deliver cannabinoids into the blood, so interactions and drowsiness are the same questions as with anything swallowed.
Prescription cannabinoids: Epidiolex, dronabinol, nabilone
FDA-approved medicines with fixed doses, filled at a pharmacy on a prescription, not bought with a medical card. Epidiolex comes with scheduled liver tests in its label [15].
What stays with every form
- THC and CBD end up in the liver, and their interactions with your medicines do not depend on the form.
- THC causes drowsiness and slows reactions; do not drive after use.
- THC and CBD are different substances, and a finding about one does not carry over to the other.
- Only a tested, labeled product tells you how much you actually took.
All forms as a table
| Form | What it avoids | What it keeps |
|---|---|---|
| Smoking | The first pass through the liver | Smoke in the airways, shared devices, liver clearance, interactions |
| Vaping and dabbing | Burning; the first pass | Hot aerosol, unknown cartridges, strong concentrates, interactions |
| Edibles and capsules | Smoke and aerosol | Full first pass through the liver, late onset, the second-helping trap, interactions |
| Tinctures and sprays | Smoke and aerosol | Swallowed share of the dose, liver processing, interactions |
| Creams and balms | Most of the effect on the rest of the body | Skin reactions |
| Transdermal patches | Smoke, aerosol, swallowing | Cannabinoids in the blood, liver clearance, interactions |
| Prescription cannabinoids | Unknown content | Liver monitoring and interactions listed on the label |
Who should not use cannabis or CBD, and who needs extra care after DILI
Nobody has followed adults who used cannabis after an episode of DILI, so there is no measured safety profile for this exact group. What is known are the effects of CBD and THC in general, and a few situations where the studies point to extra risk.
Liver enzymes rise
The best-documented liver effect of CBD, mostly at high doses and with valproate [1].
Rash
Seen in 11.7% of people when high-dose CBD was increased quickly in trials [1]. A rash with fever can also signal an immune drug reaction.
Interactions
CBD changes the levels of some seizure medicines, blood thinners and other liver-processed drugs; see the list.
Drowsiness
THC sedates, and CBD can add to the sleepiness of clobazam, opioids and sleeping pills.
Driving
THC slows reaction time. Do not drive after use, and remember that sedating medicines make it worse.
Unknown products
Untested products can contain synthetic cannabinoids or other THC levels than stated. Synthetic Spice caused severe toxic hepatitis in one reported case [12].
Who should not use cannabis or CBD, or only with the liver team
- Anyone whose DILI is still active, or whose enzymes are above three times normal clinical guidance [1]
- People with impaired liver function, cirrhosis or a slow CYP2D6 type, and those on CYP2D6-blocking medicines cells and review [13]
- Anyone taking valproate or another liver-toxic medicine without a monitoring plan clinical data [1]
- Anyone whose liver injury followed synthetic cannabinoids or an unknown vape case report [12]
- Pregnancy and breastfeeding, a personal or family history of psychosis, and anyone who must drive or operate machinery general caution
Never stop or change a prescribed medicine to make room for cannabis. Any change goes through the doctor who prescribed it.
What science doesn’t know yet about cannabis and the liver
Much of what you read online about cannabis and the liver reaches further than the studies do. These are the open questions the researchers themselves point out.
- More than half of the studies are in mice or in liver cells, and their doses do not translate to people.
- The 3D liver cell work used cells from only two donors, both boys, so it may not reflect adults or women [20].
- The clinical data are mostly in people under 50 taking prescription CBD; there are no data on unregulated hemp CBD, and symptoms and follow-up tests were reported unevenly [1].
- No study has followed adults who used cannabis or CBD after recovering from drug-induced liver injury.
- No study has compared smoked, eaten or sublingual forms for their effect on the liver.
- THC has only been looked at in a computer model checked in cells, with no animal or human confirmation [18].
- The liver-on-chip system used only three samples and shorter exposure than the mouse study, which limits what it can confirm [16].
Where the results pull apart
A smaller dose that did more harm
In older female mice given acetaminophen, the lower dose of a CBD-rich extract led to more deaths than the higher one [19]. Effects that do not rise in a straight line with dose are hard to predict, and they are a poor basis for guessing a safe amount at home.
Mice and human cells did not fully agree
The same extract stressed mouse livers at high doses, while the human liver-on-chip gave a mixed picture with few samples [16]. Neither model replaces data from people.
How to talk to your doctor about cannabis after a liver injury
Say it plainly, to every doctor who treats your liver: what you use or are thinking of using, how much and how often. It does not change whether you get care. It changes which tests are ordered and which medicines are safe to combine, and liver specialists are asked about it far more often than patients expect.
What to bring
Tap each item when it is ready in your folder or phone.
Unsure what your numbers mean? The lab lookup places them in the guideline tables.
What the clinical review suggests doctors watch
The 2024 review of CBD and the liver suggests not starting CBD when liver enzymes are above three times the upper limit without a specialist’s input, and checking liver tests in people taking 300 mg a day or more, or with other risk factors [1]. These are points for your doctor to weigh, not a dose plan for you.
What to expect
- Questions about the injury, the drug behind it and your latest labs.
- A check of your medicines for interactions.
- A plain answer on whether now is the time, and what to measure if you go ahead.
What not to expect
- A promise that cannabis or CBD will help your liver.
- A guaranteed recommendation; the physician decides after reviewing your case.
- Advice to stop a medicine someone else prescribed.
Does drug-induced liver injury qualify for a medical marijuana card?
Rarely by itself. DILI is usually a temporary injury, while state programs list long-lasting conditions, and it almost never appears on those lists by name. What counts at an evaluation is a qualifying condition written in your records, or a state rule that leaves room for the physician’s judgment. The list in force on the day of your appointment is the one that applies.
Rarely named
DILI itself
A liver injury from a medicine is not a typical qualifying condition. Expect the physician to look at what you live with now.
Related diagnosis
A condition in your records
Epilepsy, chronic pain, cancer treatment or severe nausea are listed by many programs, if a doctor has diagnosed them.
Physician judgment
States with an open clause
Some programs let the physician certify a serious condition that is not on the list. Your state’s rules say whether yours does.
What else is in your medical records?
Programs go by diagnoses written down by a doctor, not by symptoms alone. Choose the one that fits.
Epilepsy. Listed in most programs. If valproate or Epidiolex is part of your treatment, the liver questions on this page apply to you directly; see epilepsy and medical cannabis.
Chronic pain. Many programs list it in some form. After DILI from a pain reliever it is often the real reason people ask. Bring the diagnosis and what you have tried.
Severe nausea. Some states list it, often tied to a cause such as chemotherapy. Nausea from an active liver injury needs your liver team first.
Cancer treatment. Listed almost everywhere. Some cancer drugs strain the liver, so the oncology team should see your liver panel and know about any CBD.
None of these. Then it depends on how your state words its rules and on the physician’s judgment. Start with medical marijuana laws by state, or read getting a card without a listed condition.
Medical card or buying without one: what a card changes for a liver patient
Someone checks your liver and medicines first
With a medical card
A licensed physician reviews your DILI history and your medicine list.
Buying without one
No one does.
What you know about the product
With a medical card
State-tested products with THC and CBD per serving on the label.
Buying without one
Often shelf hemp CBD or delta-8 with unchecked content.
Taxes and limits
With a medical card
In many states, lower cannabis taxes and higher purchase limits, set by state rule.
Buying without one
The full adult-use tax and limit, where adult sales exist at all.
Medical cannabis by state: status, limits, taxes and home growing
Legal status, possession limits, taxes and whether patients may grow their own all differ by state, and they change often. Each state’s current rules are on its page in medical marijuana laws by state, and the tax side is compared in medical vs recreational cannabis taxes. Many programs also let a registered caregiver buy on behalf of a patient who cannot; that, too, is set by each state’s law.
Renewing your card after a liver injury
If you already have a card, a DILI episode is new medical history. Mention it at renewal along with any medicine that was stopped or added, and bring the latest liver panel. Renewal steps for your state are covered in the medical card FAQ, and past documents stay in your account.
How the online evaluation works, what it costs and how your privacy is protected
Everything happens online with a physician licensed in your state; the full description is on the medical card page.
-
About 5 minutes
Fill in the form
Your state, your diagnoses, the liver injury and every medicine you take now. A recent liver panel helps.
-
About 15 minutes
Meet the physician
A one-on-one appointment with no trip anywhere. You agree on the time with the physician; keep an hour free around it in case the schedule runs late.
-
In as little as 15 minutes after the appointment, depending on your state
The signed recommendation
When the physician approves it, you will find the document in your account.
-
Timing set by the state
State registration
Where a state keeps a patient registry, you apply there, and the state issues the card on its own timeline.
Across 250 reviews from patients in the states where we are licensed. We do not sort them by score and do not hide the low ones.
- 150,000+patients evaluated – everyone who has been through an appointment with us, in every state where we are licensed
- Since 2017doing only this: online evaluations for medical cannabis programs, and nothing else on the side
You see the price for your state before you pay; any state registration fee is paid to the state. After payment you get a confirmation and an appointment, and whether you can go straight to a dispensary depends on your state. No recommendation is promised in advance; what happens to the fee if the physician declines is explained in the medical card FAQ. Lower prices are available for veterans and people on a low income. To move an appointment, use your appointments page; for anything else, support in your account. Your health information is handled under federal privacy rules for medical records.
Our physicians are listed on the doctors page. Yellow eyes with confusion, bleeding or a possible acetaminophen overdose need emergency care, not an online appointment.
Drug-induced liver injury and cannabis: frequently asked questions
What is drug-induced liver injury?
Damage to the liver caused by a prescription drug, an over-the-counter medicine, an herb or a supplement. It is diagnosed from blood tests after other causes are ruled out, and it usually improves once the product is stopped [4]. See the full definition.
How long does drug-induced liver injury last?
It varies with the pattern. Injury to liver cells often settles within weeks to a few months after the drug is stopped, while the cholestatic pattern can take longer. Results still abnormal after six months count as chronic DILI [4]. See recovery time.
Can drug-induced liver injury be reversed or cured?
In most people, yes: the liver recovers fully once the cause is removed. A small number develop chronic injury or liver failure. Never taking the same drug again is what keeps it from coming back.
Does drug-induced liver injury cause pain?
Often not. Some people feel a dull ache under the right ribs. Strong or sharp pain there needs a same-day check, because gallstones and other causes look similar. See symptoms.
Can drug-induced liver injury cause fever?
Yes, when the injury is driven by the immune system. Fever with a rash and a high eosinophil count can point to a reaction called DRESS, which needs urgent care [5].
Can drug-induced liver injury cause cirrhosis?
Which drugs most often cause liver injury?
Acetaminophen in overdose, antibiotics such as amoxicillin-clavulanate, tuberculosis drugs such as isoniazid, seizure medicines such as valproate, and herbal and dietary supplements. LiverTox lists each one [6]. See common culprits.
What is the ICD-10 code for drug-induced liver injury?
There is no single code. Records usually combine a K71 code for toxic liver disease (K71.9 when unspecified) with a T code that names the drug, for example T39.1X5A for acetaminophen at a normal dose [7]. The code table lists the others.
How is drug-induced liver injury diagnosed?
Is CBD bad for the liver?
It can be at high doses. In pooled trial data, CBD raised the odds of liver enzyme rises about sixfold and of DILI about fivefold compared with placebo, mostly at more than 1,000 mg a day and with valproate [1]. See how big the effect was.
Is delta-8 or hemp CBD safer for the liver?
Can I use cannabis while taking isoniazid or valproate?
Only after a doctor has reviewed it. CBD with valproate has the strongest human signal for liver injury [1]. No study here tested cannabis with isoniazid, which is itself a common cause of DILI. See interactions.
Does it matter if I eat cannabis or inhale it?
Partly. What you swallow passes through the liver before it reaches the blood; what you inhale reaches the blood first and is cleared by the liver later. Interactions apply either way, and no study has compared forms for liver safety. See forms.
Is Epidiolex the same as dispensary CBD?
No. Epidiolex is an FDA-approved prescription CBD with a fixed dose and scheduled liver tests in its label [15]. Dispensary products are tested under state rules but are not FDA-approved medicines.
Is drug-induced liver injury related to drug-induced psychosis?
No. They are different conditions with different code families: liver injury sits under K71 with a T code, while substance-induced psychosis sits among the F codes, such as F12 for cannabis-related disorders [7].
Does drug-induced liver injury qualify for a medical card?
Rarely on its own. A qualifying condition in your records, such as epilepsy or chronic pain, or a state rule that allows physician judgment is the usual route. See qualifying.
More research on cannabis and drug-induced liver injury
This page cites a selection of studies. Our research library holds every study we track on cannabis and drug-induced liver injury, from laboratory work to clinical trials, and lets you filter them by cannabinoid, study type and year.
- studies
- 30
- in people
- 16
- clinical trials
- 1
Talk to a licensed physician about your liver, your medicines and cannabis
Cannabis will not repair a liver hurt by a medicine, and CBD can add to the strain.
A physician can look at your recovery, your medicine list and your state’s rules together, and tell you whether medical cannabis has any place for the symptoms you are dealing with now.
The price for your state appears before checkout, and the decision on a recommendation rests with the physician. Yellow eyes with confusion or bleeding: call 911 instead.
Share your experience
References
24 sources
- 1. Clinical guidance for cannabidiol-associated hepatotoxicity: A narrative review. DOI: 10.1111/jgh.16730 PMID: 39228144
- 2. Health Resources and Services Administration. Poison Help. 2025.
- 3. Corydalis and Drug-Induced Liver Injury: A Series of 2 Cases. DOI: 10.14309/crj.0000000000001230 PMID: 38130480
- 4. American College of Gastroenterology. ACG Clinical Guideline: Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury. 2021.
- 5. European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Drug-induced liver injury. 2019.
- 6. National Institute of Diabetes and Digestive and Kidney Diseases. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. 2012.
- 7. Centers for Medicare & Medicaid Services. ICD-10-CM code set. 2025.
- 8. Aithal GP, Watkins PB, Andrade RJ, et al. Case definition and phenotype standardization in drug-induced liver injury. 2011.
- 9. Danan G, Teschke R. RUCAM in Drug and Herb Induced Liver Injury: The Update. 2016.
- 10. U.S. Food and Drug Administration. Guidance for Industry. Drug-Induced Liver Injury: Premarketing Clinical Evaluation. 2009.
- 11. Drug-Induced Liver Injury Network. DILIN. 2025.
- 12. Spice/K2 synthetic marijuana-induced toxic hepatitis treated with N-acetylcysteine. DOI: 10.12659/AJCR.891399 PMID: 25548903
- 13. 7-Hydroxycannabidiol and 7-carboxycannabidiol induced cytotoxicity via apoptosis and endoplasmic reticulum stress in human hepatic cells. DOI: 10.1007/s00204-025-04001-7 PMID: 40029368
- 14. Articles You Might Have Missed DOI: 10.1007/s13181-020-00817-0 PMID: 33237364
- 15. U.S. Food and Drug Administration. Epidiolex (cannabidiol) prescribing information. 2018.
- 16. Human quad liver-on-chip system as a tool toward bridging the gap between animals and humans regarding toxicology and pharmacology of a cannabidiol-rich cannabis extract. DOI: 10.1080/01480545.2024.2388292 PMID: 39155655
- 17. Characterization of the Formation of the Acyl Glucuronide Metabolite of 7-Carboxy-Cannabidiol in Human Liver, Kidney, and Intestinal Microsomes and in Vivo in Mice. DOI: 10.1021/acsmedchemlett.5c00588 PMID: 41696650
- 18. Uncovering mechanism of hepatotoxicity diseases caused by tetrahydrocannabinol based on novel network toxicology and experimental verification. DOI: 10.1038/s41598-025-97523-0 PMID: 40258948
- 19. Paradoxical Patterns of Sinusoidal Obstruction Syndrome-Like Liver Injury in Aged Female CD-1 Mice Triggered by Cannabidiol-Rich Cannabis Extract and Acetaminophen Co-Administration. DOI: 10.3390/molecules24122256 PMID: 31212965
- 20. Evaluating cannabidiol-induced liver injury with and without valproate using a three-dimensional human hepatocyte spheroid model. DOI: 10.1016/j.tiv.2025.106126 PMID: 40774642
- 21. Investigation of cannabidiol-induced cytotoxicity in human hepatic cells. DOI: 10.1016/j.tox.2024.153884 PMID: 39004336
- 22. An approach for collaborative development of a federated biomedical knowledge graph-based question-answering system: Question-of-the-Month challenges. DOI: 10.1017/cts.2023.619 PMID: 37900350
- 23. U.S. Food and Drug Administration. 5 Things to Know about Delta-8 Tetrahydrocannabinol. 2022.
- 24. U.S. Food and Drug Administration. What You Need to Know About Products Containing Cannabis or Cannabis-derived Compounds, Including CBD. 2020.















